TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial
Brief Summary: The purpose of this study is to evaluate the impact on overall survival of an intensive follow-up protocol (as practiced today at TMH) against a more cost effective follow-up protocol in patients operated for extremity sarcoma.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: PET-TDM for current indication | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: semi-annual systematic PET-TDM | Intervention Type: OTHER; Name: semi-annual systematic PET-TDM; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: PET-TDM for current indication; Assigned to Arm(s): 2
B: Arm Label: 1A; Type: N/A; Interventions: N/A | Arm Label: 1B; Type: N/A; Interventions: N/A | Arm Label: IIA; Type: N/A; Interventions: N/A | Arm Label: IIB; Type: N/A; Interventions: N/A
C: Arm Label: Standard Monitoring CEA/ Standard Imagery; Type: OTHER; Interventions: Procedure: Standard Monitoring CEA, Procedure: Standard Monitoring Imagery | Arm Label: Intensive monitoring CEA/ Standard Imagery; Type: OTHER; Interventions: Procedure: Intensive Monitoring CEA, Procedure: Standard Monitoring Imagery | Arm Label: Intensive Monitoring CEA / Intensive Monitoring Imagery; Type: OTHER; Interventions: Procedure: Intensive Monitoring CEA, Procedure: Intensive Monitoring Imagery | Arm Label: Standard Monitoring CEA/ Intensive Monitoring Imagery; Type: OTHER; Interventions: Procedure: Standard Monitoring CEA, Procedure: Intensive Monitoring Imagery | Intervention Type: PROCEDURE; Name: Standard Monitoring CEA; Assigned to Arm(s): Standard Monitoring CEA/ Intensive Monitoring Imagery, Standard Monitoring CEA/ Standard Imagery | Intervention Type: PROCEDURE; Name: Intensive Monitoring CEA; Assigned to Arm(s): Intensive Monitoring CEA / Intensive Monitoring Imagery, Intensive monitoring CEA/ Standard Imagery | Intervention Type: PROCEDURE; Name: Standard Monitoring Imagery; Assigned to Arm(s): Intensive monitoring CEA/ Standard Imagery, Standard Monitoring CEA/ Standard Imagery | Intervention Type: PROCEDURE; Name: Intensive Monitoring Imagery; Assigned to Arm(s): Intensive Monitoring CEA / Intensive Monitoring Imagery, Standard Monitoring CEA/ Intensive Monitoring Imagery
D: Arm Label: SIS.NET, Routine Follow up; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SIS.NET, Routine Follow-up | Intervention Type: BEHAVIORAL; Name: SIS.NET, Routine Follow-up; Assigned to Arm(s): SIS.NET, Routine Follow up

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home-Based Tele-Health Stroke Care: A Randomized Trial for Veterans
Brief Summary: The purpose of the proposed study is to examine a Tele-rehabilitation (TR) intervention that uses tele-health technology to improve outcomes of stroke patients after discharge to home. The primary aim is to determine the effect of TR on physical function, and secondarily to determine the effect on disability, falls-related self-efficacy, and patient satisfaction.


Options:
A: Arm Label: Traditional CI Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional CI Therapy | Arm Label: Gaming CI Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Gaming CI Therapy | Arm Label: Gaming CI Therapy with Additional Contact via Video Conference; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Gaming CI Therapy with Additional Contact via Video Conference | Arm Label: Traditional Occupational Therapy/Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional Occupational Therapy/Physical Therapy | Intervention Type: BEHAVIORAL; Name: Traditional CI Therapy; Assigned to Arm(s): Traditional CI Therapy | Intervention Type: BEHAVIORAL; Name: Gaming CI Therapy; Assigned to Arm(s): Gaming CI Therapy | Intervention Type: BEHAVIORAL; Name: Gaming CI Therapy with Additional Contact via Video Conference; Assigned to Arm(s): Gaming CI Therapy with Additional Contact via Video Conference | Intervention Type: BEHAVIORAL; Name: Traditional Occupational Therapy/Physical Therapy; Assigned to Arm(s): Traditional Occupational Therapy/Physical Therapy
B: Arm Label: Tele-visit Group; Type: EXPERIMENTAL; Interventions: Behavioral: TR intervention, Behavioral: In-home messaging device. | Arm Label: Usual Care Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: TR intervention; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: In-home messaging device.; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care Group
C: Arm Label: Telerehabilitation Therapy; Type: EXPERIMENTAL; Interventions: Device: Telerehabilitation Therapy | Arm Label: In-Clinic Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: In-Clinic Therapy | Intervention Type: DEVICE; Name: Telerehabilitation Therapy; Assigned to Arm(s): Telerehabilitation Therapy | Intervention Type: BEHAVIORAL; Name: In-Clinic Therapy; Assigned to Arm(s): In-Clinic Therapy
D: Arm Label: ankle tracking; Type: EXPERIMENTAL; Interventions: Behavioral: ankle tracking training | Arm Label: ankle movement; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ankle tracking training; Assigned to Arm(s): ankle tracking

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home-Based Tele-Health Stroke Care: A Randomized Trial for Veterans
Brief Summary: The purpose of the proposed study is to examine a Tele-rehabilitation (TR) intervention that uses tele-health technology to improve outcomes of stroke patients after discharge to home. The primary aim is to determine the effect of TR on physical function, and secondarily to determine the effect on disability, falls-related self-efficacy, and patient satisfaction.


Options:
A: N/A
B: Arm Label: Telemonitoring; Type: EXPERIMENTAL; Interventions: Procedure: Telemonitoring | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Telemonitoring; Assigned to Arm(s): Telemonitoring
C: Intervention Type: PROCEDURE; Name: management of therapy complications; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: pain therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A
D: Arm Label: Tele-visit Group; Type: EXPERIMENTAL; Interventions: Behavioral: TR intervention, Behavioral: In-home messaging device. | Arm Label: Usual Care Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: TR intervention; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: In-home messaging device.; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home-Based Tele-Health Stroke Care: A Randomized Trial for Veterans
Brief Summary: The purpose of the proposed study is to examine a Tele-rehabilitation (TR) intervention that uses tele-health technology to improve outcomes of stroke patients after discharge to home. The primary aim is to determine the effect of TR on physical function, and secondarily to determine the effect on disability, falls-related self-efficacy, and patient satisfaction.


Options:
A: Arm Label: physical fitness training; Type: EXPERIMENTAL; Interventions: Procedure: physical fitness training | Arm Label: relaxation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: relaxation | Intervention Type: PROCEDURE; Name: physical fitness training; Assigned to Arm(s): physical fitness training | Intervention Type: PROCEDURE; Name: relaxation; Assigned to Arm(s): relaxation
B: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: FAST protocol; Type: EXPERIMENTAL; Interventions: Behavioral: FAST protocol | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual care | Intervention Type: BEHAVIORAL; Name: FAST protocol; Assigned to Arm(s): FAST protocol
C: Arm Label: Exercise recommendation; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise, Exercise recommendation
D: Arm Label: Tele-visit Group; Type: EXPERIMENTAL; Interventions: Behavioral: TR intervention, Behavioral: In-home messaging device. | Arm Label: Usual Care Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: TR intervention; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: In-home messaging device.; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, 5-Group, Multinational Study to Evaluate the Efficacy, Dose Response, and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Brief Summary: This is a randomized, double-blind, placebo-controlled, parallel-design, multinational, 12-week study to compare the efficacy, dose response, and safety of tadalafil once a day versus placebo in men with signs and symptoms of benign prostatic hyperplasia, including lower urinary tract symptoms.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tablet, Drug: Placebo capsule | Arm Label: Tadalafil 5 milligram (mg); Type: EXPERIMENTAL; Interventions: Drug: Tadalafil 5 mg | Arm Label: Tamsulosin 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tamsulosin | Intervention Type: DRUG; Name: Tadalafil 5 mg; Assigned to Arm(s): Tadalafil 5 milligram (mg) | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Tamsulosin; Assigned to Arm(s): Tamsulosin 0.4 mg | Intervention Type: DRUG; Name: Placebo capsule; Assigned to Arm(s): Placebo
B: Arm Label: 5 milligrams (mg) Tadalafil; Type: EXPERIMENTAL; Interventions: Drug: Tadalafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tadalafil; Assigned to Arm(s): 5 milligrams (mg) Tadalafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 5; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 5 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1
D: Arm Label: Tadalafil; Type: EXPERIMENTAL; Interventions: Drug: tadalafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): Tadalafil

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Computer-assisted Screening for Intimate Partner Violence in Family Practice - a Randomized Controlled Trial
Brief Summary: This study tested the effectiveness of computer-assisted screening for identifying patients at risk of intimate partner violence (IPV) in a Canadian family practice. It was hypothesized that the use of computer-assisted screening among female patients would lead to higher rates of IPV discussion-opportunity and IPV detection during medical consultations, compared to patients receiving standard medical care.


Options:
A: Arm Label: Screened; Type: EXPERIMENTAL; Interventions: Other: screened | Arm Label: Universal education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: universal education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: screened; Assigned to Arm(s): Screened | Intervention Type: BEHAVIORAL; Name: universal education; Assigned to Arm(s): Universal education
B: Intervention Type: BEHAVIORAL; Name: Screening via pen and paper; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Screening via audiotape; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
D: Intervention Type: DEVICE; Name: Interactive computer based health-risk survey before doctor's visit; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Computer-assisted Screening for Intimate Partner Violence in Family Practice - a Randomized Controlled Trial
Brief Summary: This study tested the effectiveness of computer-assisted screening for identifying patients at risk of intimate partner violence (IPV) in a Canadian family practice. It was hypothesized that the use of computer-assisted screening among female patients would lead to higher rates of IPV discussion-opportunity and IPV detection during medical consultations, compared to patients receiving standard medical care.


Options:
A: Intervention Type: DEVICE; Name: Interactive computer based health-risk survey before doctor's visit; Assigned to Arm(s): N/A
B: Arm Label: Extended-release naltrexone (XR-NTX); Type: ACTIVE_COMPARATOR; Interventions: Drug: Extended-Release Naltrexone | Arm Label: Motivational Enhancement Counseling Only; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Motivational Enhancement Counseling | Intervention Type: DRUG; Name: Extended-Release Naltrexone; Assigned to Arm(s): Extended-release naltrexone (XR-NTX) | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement Counseling; Assigned to Arm(s): Motivational Enhancement Counseling Only
C: Arm Label: Methadone Maintenance; Type: EXPERIMENTAL; Interventions: Behavioral: Methadone Maintenance | Arm Label: Methadone Detoxification; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Linkage to methadone maintenance | Intervention Type: BEHAVIORAL; Name: Methadone Maintenance; Assigned to Arm(s): Methadone Maintenance | Intervention Type: BEHAVIORAL; Name: Linkage to methadone maintenance; Assigned to Arm(s): Methadone Detoxification
D: Arm Label: SBIRT Group; Type: EXPERIMENTAL; Interventions: Behavioral: SBIRT | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: SBIRT; Assigned to Arm(s): SBIRT Group | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: To Assess the Efficacy, Immuno & Safety of 2 Doses of GSK HRV Vaccine at Different Virus Concentrations in Healthy Infants Aged 2 Months & Previously Uninfected With HRV, Concurrently Given With DTPw-HBV, Hib.
Brief Summary: The purpose of this study is to test how infants respond to different strengths of the human rotavirus vaccine.


Options:
A: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A
B: Intervention Type: BIOLOGICAL; Name: Live attenuated human rotavirus vaccine; Assigned to Arm(s): N/A
C: Arm Label: Bivalent OPV 2 week interval; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bivalent OPV 2 week interval | Arm Label: Bivalent OPV 4 week interval; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bivalent OPV 4 week interval | Arm Label: Monovalent OPV 2week interval; Type: ACTIVE_COMPARATOR; Interventions: Biological: Monovalent OPV 2 week interval | Arm Label: Monovalent OPV 4 week interval; Type: ACTIVE_COMPARATOR; Interventions: Biological: Monovalent OPV 4 week interval | Arm Label: Trivalent OPV 4 week interval; Type: ACTIVE_COMPARATOR; Interventions: Biological: Trivalent OPV 4 week interval | Intervention Type: BIOLOGICAL; Name: Bivalent OPV 2 week interval; Assigned to Arm(s): Bivalent OPV 2 week interval | Intervention Type: BIOLOGICAL; Name: Bivalent OPV 4 week interval; Assigned to Arm(s): Bivalent OPV 4 week interval | Intervention Type: BIOLOGICAL; Name: Monovalent OPV 2 week interval; Assigned to Arm(s): Monovalent OPV 2week interval | Intervention Type: BIOLOGICAL; Name: Monovalent OPV 4 week interval; Assigned to Arm(s): Monovalent OPV 4 week interval | Intervention Type: BIOLOGICAL; Name: Trivalent OPV 4 week interval; Assigned to Arm(s): Trivalent OPV 4 week interval
D: Arm Label: Rotarix Group; Type: EXPERIMENTAL; Interventions: Biological: Rotarix, Biological: Tritanrix-HB+Hib, Biological: Polio Sabin | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo, Biological: Tritanrix-HB+Hib, Biological: Polio Sabin | Intervention Type: BIOLOGICAL; Name: Rotarix; Assigned to Arm(s): Rotarix Group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo Group | Intervention Type: BIOLOGICAL; Name: Tritanrix-HB+Hib; Assigned to Arm(s): Placebo Group, Rotarix Group | Intervention Type: BIOLOGICAL; Name: Polio Sabin; Assigned to Arm(s): Placebo Group, Rotarix Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: To Assess the Efficacy, Immuno & Safety of 2 Doses of GSK HRV Vaccine at Different Virus Concentrations in Healthy Infants Aged 2 Months & Previously Uninfected With HRV, Concurrently Given With DTPw-HBV, Hib.
Brief Summary: The purpose of this study is to test how infants respond to different strengths of the human rotavirus vaccine.


Options:
A: Arm Label: measles-rubella and rotavirus vaccines; Type: EXPERIMENTAL; Interventions: Biological: Rotarix vaccine, Biological: measles-rubella vaccine | Arm Label: measles-rubella vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: measles-rubella vaccine | Intervention Type: BIOLOGICAL; Name: Rotarix vaccine; Assigned to Arm(s): measles-rubella and rotavirus vaccines | Intervention Type: BIOLOGICAL; Name: measles-rubella vaccine; Assigned to Arm(s): measles-rubella and rotavirus vaccines, measles-rubella vaccine
B: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A
C: Intervention Type: BIOLOGICAL; Name: Rotavirus (vaccine); Assigned to Arm(s): N/A
D: Intervention Type: BIOLOGICAL; Name: Rotavirus; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: To Assess the Efficacy, Immuno & Safety of 2 Doses of GSK HRV Vaccine at Different Virus Concentrations in Healthy Infants Aged 2 Months & Previously Uninfected With HRV, Concurrently Given With DTPw-HBV, Hib.
Brief Summary: The purpose of this study is to test how infants respond to different strengths of the human rotavirus vaccine.


Options:
A: Arm Label: Rotarix Group; Type: EXPERIMENTAL; Interventions: Biological: Rotarix™ | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Rotarix™; Assigned to Arm(s): Rotarix Group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo Group
B: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A
C: Intervention Type: BIOLOGICAL; Name: Live attenuated human rotavirus vaccine; Assigned to Arm(s): N/A
D: Intervention Type: BIOLOGICAL; Name: Live attenuated human rotavirus vaccine; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-Label, Randomized Comparison of Duloxetine, Pregabalin, and the Combination of Duloxetine and Gabapentin Among Patients With Inadequate Response to Gabapentin for the Management of Diabetic Peripheral Neuropathic Pain
Brief Summary: To test the non-inferiority of duloxetine monotherapy as a treatment for the management of diabetic peripheral neuropathic pain as compared to pregabalin treatment among patients who have not had an adequate response to gabapentin.


Options:
A: Arm Label: Pregabalin; Type: ACTIVE_COMPARATOR; Interventions: Drug: pregabalin | Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine hydrochloride | Arm Label: Gabapentin + Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine hydrochloride, Drug: gabapentin | Intervention Type: DRUG; Name: duloxetine hydrochloride; Assigned to Arm(s): Duloxetine, Gabapentin + Duloxetine | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): Pregabalin | Intervention Type: DRUG; Name: gabapentin; Assigned to Arm(s): Gabapentin + Duloxetine
B: Arm Label: Epidural steroids; Type: EXPERIMENTAL; Interventions: Procedure: epidural steroid injection, Drug: Placebo gabapentin | Arm Label: Gabapentin; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Sham epidural steroid injection, Drug: Gabapentin | Intervention Type: PROCEDURE; Name: epidural steroid injection; Assigned to Arm(s): Epidural steroids | Intervention Type: PROCEDURE; Name: Sham epidural steroid injection; Assigned to Arm(s): Gabapentin | Intervention Type: DRUG; Name: Gabapentin; Assigned to Arm(s): Gabapentin | Intervention Type: DRUG; Name: Placebo gabapentin; Assigned to Arm(s): Epidural steroids
C: Arm Label: GEn 1200mg/day; Type: EXPERIMENTAL; Interventions: Drug: GEn 1200mg/day | Arm Label: GEn 3600mg/day; Type: EXPERIMENTAL; Interventions: Drug: GEn 3600mg/day | Intervention Type: DRUG; Name: GEn 1200mg/day; Assigned to Arm(s): GEn 1200mg/day | Intervention Type: DRUG; Name: GEn 3600mg/day; Assigned to Arm(s): GEn 3600mg/day
D: Arm Label: Sham-laser acupuncture; Type: SHAM_COMPARATOR; Interventions: Device: Sham-laser acupuncture | Arm Label: gabapentine; Type: ACTIVE_COMPARATOR; Interventions: Drug: gabapentine | Arm Label: Acupuncture; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Acupuncture | Intervention Type: DEVICE; Name: Sham-laser acupuncture; Assigned to Arm(s): Sham-laser acupuncture | Intervention Type: DRUG; Name: gabapentine; Assigned to Arm(s): gabapentine | Intervention Type: PROCEDURE; Name: Acupuncture; Assigned to Arm(s): Acupuncture

Answer: A